Pediatric growth hormone deficiency (PGHD) is a genetic condition that affects your child’s physical development. Hormone replacement therapy can help promote growth, and a new injection now makes it ...

Skytrofa is a long-acting form of somatropin. Somatropin is also called human growth hormone. Skytrofa is also considered a pegylated somatropin product. Pegylated means the medication is attached to ...

Please provide your email address to receive an email when new articles are posted on . The FDA approved long-acting once-weekly somatrogon for children with growth hormone deficiency. Somatrogon was ...

The rate of growth in children varies with the season while higher latitude and greater summer daylight exposure makes a significant difference in results for children treated with growth hormone, ...

A standard-dose recombinant growth hormone therapy administered for 2 years demonstrated positive effects on both growth and nutritional status in prepubertal children with Silver-Russell syndrome, a ...

Gone are the days when we used to think that the only factor that determines a child's height is the genes. According to paediatric‑endocrinologists there are a lot of things that come into play.

Children with growth hormone deficiency (GHD) had reduced physical fitness and lower levels of physical activity than control individuals without the condition, but 1 year of growth hormone ...